17 Einträge gefunden

1. Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.

   1. Klyuchnikov, Evgeny
   2. Holler, Ernst
   3. Bornhäuser, Martin
   4. Kobbe, Guido
   5. Nagler, Arnon
   6. Shimoni, Avichai
   7. Könecke, Christian

   2012 - Forschungsinformationssystem des UKE
2. Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Eder, Christiane
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Grossmann, Vera
   7. Kohlmann, Alexander

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
3. Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies.

   1. Bacher, Ulrike
   2. Talano, Julie-An
   3. Bishop, Michael R

   2012 - Forschungsinformationssystem des UKE
4. Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogeneic stem cell transplantation

   1. Rahlff, Janina
   2. Trusch, Maria
   3. Haag, Friedrich
   4. Bacher, Ulrike
   5. Horst, Andrea Kristina
   6. Schlüter, Hartmut
   7. Binder, Mascha

   2012 - Forschungsinformationssystem der UHH
5. Critical imbalance of TNF-α and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment.

   1. Flammiger, Anna
   2. Fiedler, Walter
   3. Bacher, Ulrike
   4. Bokemeyer, Carsten
   5. Schneider, Marion
   6. Binder, Mascha

   2012 - Forschungsinformationssystem des UKE
6. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.

   1. Haferlach, Claudia
   2. Bacher, Ulrike
   3. Schnittger, Susanne
   4. Alpermann, Tamara
   5. Zenger, Melanie
   6. Kern, Wolfgang
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
7. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.

   1. Bacher, Ulrike
   2. Kern, Wolfgang
   3. Alpermann, Tamara
   4. Schnittger, Susanne
   5. Haferlach, Claudia
   6. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
8. Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Alpermann, Tamara
   4. Reiter, Andreas
   5. Ulke, Madlen
   6. Dicker, Frank
   7. Eder, Christiane

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
9. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.

   1. Shah, Nirali N
   2. Bacher, Ulrike
   3. Fry, Terry
   4. Calvo, Katherine R
   5. Stetler-Stevenson, Maryalice
   6. Arthur, Diane C
   7. Kurlander, Roger

   2012 - Forschungsinformationssystem des UKE
10. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

    1. Bacher, Ulrike
    2. Weissmann, Sandra
    3. Kohlmann, Alexander
    4. Schindela, Sonja
    5. Alpermann, Tamara
    6. Schnittger, Susanne
    7. Kern, Wolfgang

    2012 - Forschungsinformationssystem des UKE
11. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.

    1. Kern, Wolfgang
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Dicker, Frank
    5. Alpermann, Tamara
    6. Schnittger, Susanne
    7. Haferlach, Torsten

    2012 - Forschungsinformationssystem des UKE
12. Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogeneic stem cell transplantation.

    1. Rahlff, Janina
    2. Trusch, Maria
    3. Haag, Friedrich
    4. Bacher, Ulrike
    5. Horst, Andrea
    6. Schlüter, Hartmut
    7. Binder, Mascha

    2012 - Forschungsinformationssystem des UKE
13. Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

    1. Bacher, Ulrike
    2. Klyuchnikov, Evgeny
    3. Le-Rademacher, Jennifer
    4. Carreras, Jeanette
    5. Armand, Philippe
    6. Bishop, Michael R
    7. Bredeson, Christopher N

    2012 - Forschungsinformationssystem des UKE
14. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.

    1. Haferlach, Torsten
    2. Bacher, Ulrike
    3. Alpermann, Tamara
    4. Haferlach, Claudia
    5. Kern, Wolfgang
    6. Schnittger, Susanne

    2012 - Forschungsinformationssystem des UKE
15. Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia.

    1. Kern, Wolfgang
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Alpermann, Tamara
    5. Dicker, Frank
    6. Schnittger, Susanne
    7. Haferlach, Torsten

    2012 - Forschungsinformationssystem des UKE
16. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Torsten
    4. Wendland, Nicole
    5. Ulke, Madlen
    6. Dicker, Frank
    7. Grossmann, Vera

    2012 - Forschungsinformationssystem des UKE
17. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

    1. Bacher, Ulrike
    2. Schnittger, Susanne
    3. Macijewski, Katja
    4. Grossmann, Vera
    5. Kohlmann, Alexander
    6. Alpermann, Tamara
    7. Kowarsch, Andreas

    2012 - Forschungsinformationssystem des UKE